- Impact of Sarcopenia, BMI, and Inflammatory Biomarkers on Survival in Advanced Hepatocellular Carcinoma Treated With Anti-PD-1 Antibody
Mehmet Akce et al, 2021, American Journal of Clinical Oncology CrossRef - Fat-free muscle area measured by magnetic resonance imaging predicts overall survival of patients undergoing radioembolization of colorectal cancer liver metastases
Anton Faron et al, 2019, European Radiology CrossRef - Calculated body muscle mass as a useful screening marker for low skeletal muscle mass and sarcopenia in chronic liver disease
Tatsuki Ichikawa et al, 2020, Hepatology Research CrossRef - Radiological psoas muscle parameters as a reliable tool for detection of sarcopenia and prediction of short-term survival in liver cirrhosis
V. M. Motsiuk et al, 2022, Reports of Morphology CrossRef - What Is the Role of Body Composition Assessment in HCC Management?
Pompilia Radu et al, 2022, Cancers CrossRef - The Negative Impact of Sarcopenia on Hepatocellular Carcinoma Treatment Outcomes
Annalisa Cespiati et al, 2024, Cancers CrossRef - Sarcopenia Worsening One Month after Transarterial Radioembolization Predicts Progressive Disease in Patients with Advanced Hepatocellular Carcinoma
Giulio Eugenio Vallati et al, 2021, Biology CrossRef - Sarcopenia is associated with reduced survival in patients with advanced hepatocellular carcinoma undergoing sorafenib treatment
Giulio Antonelli et al, 2018, United European Gastroenterology Journal CrossRef - Skeletal muscle mass is associated with toxicity, treatment tolerability, and additional or subsequent therapies in patients with hepatocellular carcinoma receiving sorafenib treatment
Koji Sawada et al, 2019, JGH Open CrossRef - Psoas Muscle Index: A Simple and Reliable Method of Sarcopenia Assessment on Computed Tomography Scan in Chronic Liver Disease and its Impact on Mortality
Gajanan A. Rodge et al, 2023, Journal of Clinical and Experimental Hepatology CrossRef - Skeletal muscle volume loss during transarterial chemoembolization predicts poor prognosis in patients with hepatocellular carcinoma
Masashi Fujita et al, 2019, Hepatology Research CrossRef - Radiological Assessment of Sarcopenia and Its Clinical Impact in Patients with Hepatobiliary, Pancreatic, and Gastrointestinal Diseases: A Comprehensive Review
Shameema Farook et al, 2024, Journal of Gastrointestinal and Abdominal Radiology CrossRef - Clinical impact of sarcopenia assessment in patients with liver cirrhosis
Giovanni Marasco et al, 2021, Expert Review of Gastroenterology & Hepatology CrossRef - Skeletal muscle volume loss among liver cirrhosis patients receiving levocarnitine predicts poor prognosis
Masashi Fujita et al, 2020, Medicine CrossRef - Indices calculated by serum creatinine and cystatin C as predictors of liver damage, muscle strength and sarcopenia in liver disease
Tatsuki Ichikawa et al, 2020, Biomedical Reports CrossRef - Clinical impact of sarcopenia assessment in patients with hepatocellular carcinoma undergoing treatments
Giovanni Marasco et al, 2020, Journal of Gastroenterology CrossRef - Impact of Sarcopenia on the Survival of Patients with Hepatocellular Carcinoma Treated with Sorafenib
Maurizio Biselli et al, 2024, Cancers CrossRef - Sarcopenia in hepatocellular carcinoma: Current knowledge and future directions
Abhilash Perisetti et al, 2022, World Journal of Gastroenterology CrossRef - The Deterioration of Sarcopenia Post-Transarterial Radioembolization with Holmium-166 Serves as a Predictor for Disease Progression at 3 Months in Patients with Advanced Hepatocellular Carcinoma: A Pilot Study
Claudio Trobiani et al, 2024, Journal of Personalized Medicine CrossRef - Automated Measurements of Muscle Mass Using Deep Learning Can Predict Clinical Outcomes in Patients With Liver Disease
Nicholas C. Wang et al, 2020, American Journal of Gastroenterology CrossRef - Influence of skeletal muscle volume loss during lenvatinib treatment on prognosis in unresectable hepatocellular carcinoma: a multicenter study in Tohoku, Japan
Masashi Fujita et al, 2022, Scientific Reports CrossRef - Sarcopenia in chronic advanced liver diseases: A sex-oriented analysis of the literature
Maria Guarino et al, 2022, Digestive and Liver Disease CrossRef - Total skeletal, psoas and rectus abdominis muscle mass as prognostic factors for patients with advanced hepatocellular carcinoma
Chih-Horng Wu et al, 2021, Journal of the Formosan Medical Association CrossRef - Clinical Significance of Sarcopenia in Patients with Advanced Hepatocellular Carcinoma Undergoing Sorafenib Treatment
Min-Hyuk Lee et al, 2021, Annals of Clinical Nutrition and Metabolism CrossRef